Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Meuleman

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
JHEP Reports : Innovation in Hepatology|April 17, 2025
A novel <i>in vitro</i> system for simultaneous infections with hepatitis B, C, D and E virusesRoxanne Fouillé, Eloi R Verrier, Amse De Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy functionToni Luise Meister, Yannick Brüggemann, Maximilian K Nocke, et al.
Journal of Virology|March 7, 2014
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responsesAlicja M Chmielewska, Mariarosaria Naddeo, Stefania Capone, et al.
Plos Pathogens|June 28, 2022
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivoChristian Heuss, Paul Rothhaar, Rani Burm, et al.
Gut|August 27, 2015
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver miceKoen Vercauteren, Richard J P Brown, Ahmed Atef Mesalam, et al.
Gastroenterology|September 26, 2015
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing AntibodiesCatherine Fauvelle, Daniel J Felmlee, Emilie Crouchet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2020
Robust hepatitis E virus infection and transcriptional response in human hepatocytesDaniel Todt, Martina Friesland, Nora Moeller, et al.
Gastroenterology|September 30, 2017
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid ProteinClaire Montpellier, Czeslaw Wychowski, Ibrahim M Sayed, et al.
Nature Microbiology|January 24, 2017
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Nature Microbiology|December 20, 2016
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
JHEP Reports : Innovation in Hepatology|April 17, 2025
A novel <i>in vitro</i> system for simultaneous infections with hepatitis B, C, D and E virusesRoxanne Fouillé, Eloi R Verrier, Amse De Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy functionToni Luise Meister, Yannick Brüggemann, Maximilian K Nocke, et al.
Journal of Virology|March 7, 2014
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responsesAlicja M Chmielewska, Mariarosaria Naddeo, Stefania Capone, et al.
Plos Pathogens|June 28, 2022
A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivoChristian Heuss, Paul Rothhaar, Rani Burm, et al.
Gut|August 27, 2015
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver miceKoen Vercauteren, Richard J P Brown, Ahmed Atef Mesalam, et al.
Gastroenterology|September 26, 2015
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing AntibodiesCatherine Fauvelle, Daniel J Felmlee, Emilie Crouchet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2020
Robust hepatitis E virus infection and transcriptional response in human hepatocytesDaniel Todt, Martina Friesland, Nora Moeller, et al.
Gastroenterology|September 30, 2017
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid ProteinClaire Montpellier, Czeslaw Wychowski, Ibrahim M Sayed, et al.
Nature Microbiology|January 24, 2017
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Nature Microbiology|December 20, 2016
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureChristian Harak, Max Meyrath, Inés Romero-Brey, et al.
Pageof 13